Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Obama Says Peanut Butter Problem Points To “Full Review” Of FDA

This article was originally published in The Tan Sheet

Executive Summary

President Obama plans a "full review" of FDA, saying the agency should be able to act earlier to address problems such as the ongoing recalls related to peanut butter products stop the distribution of contaminated peanut butter ingredients

You may also be interested in...



Hamburg/Sharfstein Appointments Do Not Signal Split Duties At FDA

FDA's top leadership team will not split duties along food and medical products, sources close to the selection process say

Hamburg/Sharfstein Appointments Do Not Signal Split Duties At FDA

FDA's top leadership team will not split duties along food and medical products, sources close to the selection process say

Obama Appoints Inter-Agency Working Group To Revamp Food Safety

An inter-agency group will advise President Obama "as soon as possible" on improving food safety enforcement across federal agencies

Related Content

Topics

UsernamePublicRestriction

Register

PS102591

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel